Health

FDA Approves Blujepa: A New Class of Oral Antibiotic for Urinary Tract Infections

FDA greenlights Blujepa, the first new oral antibiotic for uUTIs in 30 years, targeting resistance with a novel dual enzyme mechanism.

#fda, #antibiotics, #urinary tract infections, #gsk, #healthcare

Benralizumab Shows Promise Over Prednisolone in Treating Severe Asthma

Study finds benralizumab more effective than prednisolone for severe asthma, reducing treatment needs by 30%. Published in The Lancet.

#asthma, #COPD, #benralizumab, #healthcare, #research

FDA Approves First CRISPR-Based Gene-Editing Therapy for Sickle Cell Disease

FDA approves Casgevy, the first CRISPR-based therapy, offering hopes for sickle cell disease patients. A milestone in gene-editing breakthroughs.

#health, #CRISPR, #gene-editing, #sickle cell disease, #FDA approval

HHS Layoffs and Restructuring Under Health Secretary Kennedy Spark Concerns

HHS restructuring under Robert F. Kennedy Jr. raises concerns over layoffs and potential impacts on public health data analysis.

#HHS, #layoffs, #public health, #Robert F. Kennedy Jr., #NSDUH

Measles Outbreak in the U.S. Reaches 642 Cases Across 22 States

The U.S. battles a measles outbreak with 642 cases in 22 states, emphasizing the urgent need for vaccination among unvaccinated populations.

#health, #measles, #vaccination, #public health, #outbreak

Study Reveals High Levels of Microplastics in Human Brains

Microplastics found in human brains, potentially linked to dementia, emphasize the need for urgent research on their health impacts.

#microplastics, #health, #neurology, #pollution

FDA's Dr. Peter Marks Resigns Amid Controversy Over Vaccine Misinformation

Dr. Peter Marks resigns as Director of the CBER at the FDA, citing Health and Human Services Secretary RFK Jr.'s vaccine misinformation. His departure highlights the clash between political appointments and scientific integrity.

#fda, #peter marks, #vaccine misinformation, #rfk jr, #health